BioMed Research International

MicroRNA and Cardiovascular Disease


Status
Published

Lead Editor

1Central South University, Changsha, China

2Stanford University, Stanford, USA

3Warsaw University of Life Sciences, Warsaw, Poland

4Chang Gung Memorial Hospital, Keelung, Taiwan


MicroRNA and Cardiovascular Disease

Description

Cardiovascular disease (CVD) is the leading cause of death and the most expensive health condition throughout the world, killing nearly 17 million people in 2011 around the world. During the past decade, there have been significant advances in our knowledge of the pathogenesis, diagnosis, and treatment in CVD. Recently, microRNAs (miRNAs) have emerged as being one of the most important gene regulators of widespread cellular function. However, we still do not have a complete understanding of the underlying mechanisms and pathological roles of miRNAs in cardiovascular tissue, whereas miRNAs represent a promising group of critical regulators of cardiovascular physiology and novel targets for prevention and treatment of CVD.

We sincerely invite researchers to contribute original research articles as well as review articles to this special issue, which will report the most recent results and progress about the involvement of miRNAs in CVD.

Potential topics include, but are not limited to:

  • miRNAs function in CVD
  • miRNAs as biomarkers of CVD
  • miRNAs as potential therapeutic targets of CVD
  • miRNAs expression changes after common pharmaceutical or surgical treatment for CVD
  • Bioinformatics study of microRNA in CVD

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 734380
  • - Editorial

MicroRNA and Cardiovascular Disease

Xiao-Bo Liao | Vinicio A. de Jesus Perez | ... | Ling-Qing Yuan
  • Special Issue
  • - Volume 2015
  • - Article ID 354517
  • - Review Article

Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling

Dmitry A. Chistiakov | Igor A. Sobenin | ... | Yuri V. Bobryshev
  • Special Issue
  • - Volume 2015
  • - Article ID 320849
  • - Review Article

The Role of Epigenetics in Arterial Calcification

Shan-Shan Wu | Xiao Lin | ... | Er-Yuan Liao
  • Special Issue
  • - Volume 2015
  • - Article ID 624037
  • - Research Article

Runx2/miR-3960/miR-2861 Positive Feedback Loop Is Responsible for Osteogenic Transdifferentiation of Vascular Smooth Muscle Cells

Zhu-Ying Xia | Yin Hu | ... | Hui Xie
  • Special Issue
  • - Volume 2015
  • - Article ID 831641
  • - Review Article

MicroRNAs: Novel Players in Aortic Aneurysm

Xian-ming Fu | Yang-zhao Zhou | ... | Xin-min Zhou
  • Special Issue
  • - Volume 2015
  • - Article ID 531740
  • - Review Article

MicroRNA-143/-145 in Cardiovascular Diseases

Wang Zhao | Shui-Ping Zhao | Yu-Hong Zhao
  • Special Issue
  • - Volume 2015
  • - Article ID 497280
  • - Research Article

miR-126 Is Involved in Vascular Remodeling under Laminar Shear Stress

Ana Mondadori dos Santos | Laurent Metzinger | ... | Valérie Metzinger-Le Meuth
  • Special Issue
  • - Volume 2015
  • - Article ID 391306
  • - Research Article

miR-27 and miR-125 Distinctly Regulate Muscle-Enriched Transcription Factors in Cardiac and Skeletal Myocytes

Estefania Lozano-Velasco | Jennifer Galiano-Torres | ... | Diego Franco
  • Special Issue
  • - Volume 2015
  • - Article ID 981841
  • - Review Article

The Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet Therapy

Rui Shi | Xin Zhou | ... | Yu-Ming Li
  • Special Issue
  • - Volume 2015
  • - Article ID 263151
  • - Research Article

A MicroRNA-Transcription Factor Blueprint for Early Atrial Arrhythmogenic Remodeling

Mario Torrado | Diego Franco | ... | Alexander Mikhailov
BioMed Research International
 Journal metrics
Acceptance rate30%
Submission to final decision66 days
Acceptance to publication36 days
CiteScore3.600
Impact Factor2.276
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.